Subscribe to Newsletter

Cornea / Ocular Surface

teaser of 0515-803
Subspecialties Cornea / Ocular Surface

Current Treatment Options in Dry Eye Disease

| Sponsored by Santen Pharmaceuticals

Managing dry eye disease becomes disproportionately more difficult as the severity of the disease increases: artificial tears and lubricants are not enough to help patients with severe dry eye disease.

Subspecialties Cornea / Ocular Surface

Dry Eye Disease’s Diagnostic Challenge

| Sponsored by Santen Pharmaceuticals

The multifactorial nature of dry eye disease means that often, there’s a discordance between signs and symptoms, confounding diagnosis. Can things be improved?

Subspecialties Cornea / Ocular Surface

Classifying Keratoconus – Classically

There’s still a place for retinoscopy in the diagnosis and staging of corneal ectasias

Subspecialties Cornea / Ocular Surface

Reducing Corneal Graft Rejection on a Very Small Scale

Nanoparticles deliver sustained corticosteroid levels to prevent corneal graft rejection

Subspecialties Cornea / Ocular Surface

Epi-On or Epi-Off?

| Frederik Raiskup

Corneal cross-linking can halt the progression of keratoconus, but what is the best approach to treatment?

Subspecialties Cornea / Ocular Surface

Next month

| Sponsored by Santen Pharmaceuticals

Dry Eye Disease’s Big Diagnostic Challenge

Subspecialties Cornea / Ocular Surface

The Burden of Dry Eye Disease

| Sponsored by Santen Pharmaceuticals

With many causes, great prevalence, and substantial underdiagnosis, dry eye disease poses a great burden on patients and your practice

Subspecialties Cornea / Ocular Surface

It’s Time to Make a Move…

| Theo Seiler, Bojan Pajic, Jodhbir (Jod) Mehta, Luis Izquierdo Jr.

To The New Femtosecond Laser Generation

Subspecialties Cornea / Ocular Surface

Kerarings in the Clinic

My experience with Keraring intrastromal corneal ring segments in corneal ectasia

Subspecialties Cornea / Ocular Surface

Accelerating PACK-CXL

| Mark Hillen

Increasing the intensity of illumination degrades the efficacy of regular CXL, but it doesn’t seem to with PACK-CXL. Why?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: